About 310 AI
310 AI is a Healthcare company based in San Francisco (United States) founded in 2022. AI-based computational tools for drug discovery and research are provided. Its website 310.ai draws about 18 thousand monthly visits. 310 AI offers products and services including AI Copilot and Molecular Programming Model. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Similar companies include Asimov, Cellarity and Metaphore; 3 of its 3 listed similar companies have raised funding.
Company details
310 AI was founded in 2022 and is headquartered in San Francisco, United States. Computational model tools powered by artificial intelligence are developed for applications in drug discovery and scientific research. Operations center on the biotechnology sector, where services support pharmaceutical development through advanced modeling techniques. The companys domain, 310.ai, facilitates access to these tools for researchers and organizations in the field.
Products & Services of 310 AI
310 AI offers a comprehensive portfolio of products and services, including AI Copilot and Molecular Programming Model.
Web-based tool for designing biomolecules using AI models.
Generates protein sequences from textual descriptions for biology.
Apps and channels of 310 AI
its YouTube channel 310 AI has 1.21K subscribers and 30 videos.
Videos from 310 AI
The most watched videos on 310 AI's YouTube channel, 310 AI (1.21K subscribers). Click a video to play it here.
More on 310 AI.
People of 310 AI
2 people are tracked at 310 AI (2 in leadership).
| Name | Role | Group |
|---|---|---|
Kathy Y. Wei, Ph.D. | CSO & Co-founder | Leadership |
Kooshiar Azimian | Founder & CEO | Leadership |
Complete people profiles for 310 AI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to 310 AI
310 AI has 3 listed similar companies in our database, 3 of them funded. They include Asimov, Cellarity and Metaphore.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asimov.com | 2017 | Boston, United States | $209.4M | 87 | Provider of integrated suite for advanced genetic design and manufacturing | |
| cellarity.com | 2015 | Cambridge, United States | $294M | 117 | Developer of drugs to treat various diseases | |
| metaphorebio.com | 2021 | Cambridge, United States | $50M | Provider of machine language and computational platform for drug discovery |
Detailed similar companies of 310 AI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of 310 AI
The website of 310 AI (310.ai) receives about 17.7K visits a month.
- Monthly visits17.7K
▼ 18.2% vs previous month
Websites whose visitors overlap most with 310 AI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| scichart.com | 100% | #436,458 | View details | ||
| google.com | 59% | 85.8B | #1 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as 310 AI (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about 310 AI
310 AI was founded in 2022.
310 AI is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
310 AI was founded in 2022 and is headquartered in San Francisco, United States. Computational model tools powered by artificial intelligence are developed for applications in drug discovery and scientific research. Operations center on the biotechnology sector, where services support pharmaceutical development through advanced modeling techniques. The companys domain, 310.ai, facilitates access to these tools for researchers and organizations in the field.
310 AI offers AI Copilot and Molecular Programming Model.